Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Well diffusion for antifungal susceptibility testing
2003637 citationsS Magaldi, Sofía Mata‐Essayag et al.International Journal of Infectious Diseasesprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of S Magaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Magaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Magaldi more than expected).
This network shows the impact of papers produced by S Magaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Magaldi. The network helps show where S Magaldi may publish in the future.
Co-authorship network of co-authors of S Magaldi
This figure shows the co-authorship network connecting the top 25 collaborators of S Magaldi.
A scholar is included among the top collaborators of S Magaldi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Magaldi. S Magaldi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
Colella, María Teresa, et al.. (2007). Identificación de Histoplasma capsulatum en muestras clínicas mediante la técnica de PCR en dos rondas. Redalyc (Universidad Autónoma del Estado de México). 35(2). 156–163.3 indexed citations
2.
Mata‐Essayag, Sofía, et al.. (2007). Neonatal candidiasis in Venezuela: clinical and epidemiological aspects.. PubMed. 47(1-2). 11–20.9 indexed citations
3.
Mata‐Essayag, Sofía, et al.. (2004). Antifungal activity of nucleoside analogues and non-nucleoside reverse transcriptase inhibitors. Journal de Mycologie Médicale. 14(3). 123–128.
4.
Pérez, Claudio F., et al.. (2003). Identification of Cryptococcus neoformans var. gattii by canavanine glycine bromothymol blue medium (CGB).. Revista de la Sociedad Venezolana de Microbiología. 23(2). 158–162.1 indexed citations
5.
Pérez, Claudio F., et al.. (2003). Identificación de Cryptococcus neoformans var. gattii mediante el uso del medio canavanina-glicina-azul de bromotimol (CGB).. Revista de la Sociedad Venezolana de Microbiología. 23(2). 158–162.1 indexed citations
6.
Reyes, Horacio, Sabrina Matà, S Magaldi, et al.. (2003). Utilidad del método LA-Sporothrix Antibody System en el diagnóstico de la esporotricosis cutánea.. Revista de la Sociedad Venezolana de Microbiología. 23(2). 163–165.1 indexed citations
7.
Magaldi, S, Sofía Mata‐Essayag, Claudia Hartung de Capriles, et al.. (2003). Well diffusion for antifungal susceptibility testing. International Journal of Infectious Diseases. 8(1). 39–45.637 indexed citations breakdown →
Magaldi, S, et al.. (2001). In vitro susceptibility to fluconazole of Candida spp. isolates comparing three different methods. Journal de Mycologie Médicale. 11(3). 123–126.11 indexed citations
Magaldi, S, et al.. (2000). Considerazioni sulle proprietà geotecniche dei suoli allofanici di copertura delle dorsali carbonatiche campane. 143–155.8 indexed citations
14.
Magaldi, S, et al.. (1998). Pruebas de sensibilidad de Candida albicans frente a los antimicóticos de uso comercial. 16–20.6 indexed citations
15.
Magaldi, S, et al.. (1997). Suceptibilidad de Candida albicans "In vitro" mediante los posos de difusión. 5–8.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.